Respiratory research
June 20, 2026
2 min readIP Score 10/10
Ultrasonic elastography-guided pleural biopsy followed by as-needed semi-rigid thoracoscopic pleural biopsy versus immediate semi-rigid thoracoscopic pleural biopsy for the diagnosis of pleural effusion (UPDATE-3): a protocol of randomised controlled trial.
Liao L; Ma J; Ni J; Lin J; Zhao S; Xia Y
Abstract
INTRODUCTION: Exudative pleural effusion of an unclear aetiology remains a diagnostic challenge. Ultrasonic elastography-guided pleural biopsy (UEPB) offers a higher diagnostic yield than conventional ultrasound-guided pleural biopsy; however, its role relative to semi-rigid thoracoscopy remains unclear. This trial is designed to determine whether UEPB is non‑inferior to semi-rigid thoracoscopy in diagnostic yield when used as the initial diagnostic procedure, and to further quantify the proportion of patients in whom semi-rigid thoracoscopy could be avoided by adopting a UEPB-first diagnostic strategy. METHODS AND ANALYSIS: In this multicentre, open-label, parallel-group, non-inferiority, randomised controlled trial conducted at five sites in China, 420 patients with exudative pleural effusion of unknown aetiology and negative cytology will be randomly assigned 1:1 to either initial UEPB (with semi-rigid thoracoscopy reserved for non-diagnostic cases) or immediate semi-rigid thoracoscopy. The primary outcome is the overall diagnostic yield of the allocated diagnostic strategy, defined as the proportion of participants in whom a specific histopathological diagnosis is stablished through the protocol-defined biopsy procedures within the allocated diagnostic pathway. A non-inferiority margin of - 5% is applied. The secondary outcomes included diagnostic sensitivity in specific disease, procedure-related adverse events, length of hospital stay, duration of chest tube drainage, thoracoscopy avoidance rate, and direct diagnostic pathway-related medical costs. DISCUSSION: This UPDATE-3 study will provide the evidence from a RCT directly comparing the a UEPB-first step-up diagnostic strategy with immediate semi-rigid thoracoscopy in patients with undiagnosed exudative pleural effusion. Should non-inferiority be established, UEPB will be validated as a sufficiently sensitive first-line biopsy technique. Furthermore, this trial will quantify the extent to which a UEPB-first strategy can safely decrease the necessity for semi-rigid thoracoscopy and optimize healthcare utilization. These findings could facilitate a paradigm shift towards a less invasive, step-up diagnostic pathway. Conversely, should non-inferiority not be established, the findings will reinforce the status of semi-rigid thoracoscopy as the diagnostic reference standard and elucidate the appropriate role of UEPB within the diagnostic algorithm. TRIAL REGISTRATION: ClinicalTrials.gov (Registration ID: NCT07419620; Registration Date: 2026-02-12).
This case highlights the diagnostic and management challenges of refractory multisystem sarcoidosis progressing over a two-year period despite advanced biologic therapy.
Clinicians should note that the presence of targetable mutations in non-small cell lung cancer with malignant pleural disease is not associated with improved survival, based on the findings from this study.
Shape-sensing robotic-assisted bronchoscopy achieved a strict diagnostic yield of 70.2% with a low pneumothorax rate of 3.3%, demonstrating that earlier tissue diagnosis of very small pulmonary nodules is feasible and safe for clinical practice.
Up nextJournal of Thoracic DiseaseOct 30, 2026Read
This study introduces ultrasound-guided trans-cannula cryobiopsy of supraclavicular lymph nodes as a novel superficial lymph node approach for tissue acquisition in 10 consecutive patients, though specific numeric success or safety results were not provided in the abstract.
Active infection is not an absolute contraindication to endobronchial valve placement, but positive pressure ventilation significantly increases clinical failure odds with an aOR of 3.00 at P < 0.001.